Grandeur Peak Global Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.4M Buy
587,399
+205,497
+54% +$5.78M 3.8% 7
2026
Q1
$10.9M Buy
381,902
+53,411
+16% +$1.82M 2.55% 9
2025
Q4
$13M Buy
328,491
+249,591
+316% +$9.15M 1.75% 12
2025
Q3
$2.78M Buy
+78,900
New +$2.72M 0.37% 59
2025
Q1
Sell
-242,791
Closed -$7.42M 115
2024
Q4
$7.42M Sell
242,791
-86,478
-26% -$2.78M 0.66% 39
2024
Q3
$9.23M Sell
329,269
-43,915
-12% -$1.08M 0.77% 39
2024
Q2
$8.5M Buy
373,184
+28,154
+8% +$650K 0.68% 45
2024
Q1
$10.5M Buy
345,030
+113,480
+49% +$3.8M 0.83% 34
2023
Q4
$8.26M Buy
+231,550
New +$8.61M 0.58% 41

Other funds holding ATRC

Grandeur Peak Global Advisors's ATRC Position: Q2 2026 in Review

Grandeur Peak Global Advisors increased its AtriCure (ATRC) stake by 54% in Q2 2026, buying an estimated $5.78M and bringing the position to 587,399 shares worth $16.4M. The position accounts for 3.8% of the portfolio, ranked #7.

Grandeur Peak Global Advisors first reported a position in ATRC in Q4 2023 and has held it in 9 quarters since. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Grandeur Peak Global Advisors held 587,399 shares of AtriCure worth $16.4M as of Q2 2026.
  • Grandeur Peak Global Advisors bought 205,497 AtriCure shares in Q2 2026, an estimated $5.78M.
  • AtriCure made up 3.8% of Grandeur Peak Global Advisors's portfolio in Q2 2026, its #7 holding.
  • Grandeur Peak Global Advisors first reported a position in AtriCure in Q4 2023 and has held it in 9 quarters since.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Grandeur Peak Global Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.